Medicinal Genomics

Medicinal Genomics is pioneering the genomics of medical cannabis and hemp. In 2011, Medicinal Genomics made worldwide headlines for being the first group to decode the Cannabis Genome. An increasing amount of scientific evidence supports the theory that cannabinoid compounds may have numerous medical benefits. Medicinal Genomics has the largest DNA sequence database of the cannabis plant and is well-positioned to design fingerprinting assays for strain genotyping and sequencing services for strain development.  In 2011, Medicinal Genomics was acquired by Courtagen Life Sciences, Inc.

Medicinal Genomics is a biotechnology company focused on developing genomic solutions for the cannabis industry. Their core offerings include advanced genomic testing services and tools to aid in the cultivation, analysis, and breeding of cannabis plants. Medicinal Genomics has pioneered the sequencing of the entire genomes of Cannabis sativa and Cannabis indica, assembling the largest known gene collection of this therapeutic plant as of September 2022.

Solutions for Safe, Quality Cannabis

Medicinal Genomics Sequences the Cannabis Genome to Assemble the Largest Known Gene Collection of this Therapeutic Plant

Social and cultural shifts accompanied by changes in laws spark new opportunities

Cannabis

Medicinal Genomics on LinkedIn: Pythium causes root browning, root rot, and crown rot, resulting in…

Medicinal Genomics is a biotechnology company focused on developing genomic solutions for the cannabis industry. Their core offerings include advanced genomic testing services and tools to aid in the cultivation, analysis, and breeding of cannabis plants. Medicinal Genomics has pioneered the sequencing of the entire genomes of Cannabis sativa and Cannabis indica, assembling the largest known gene collection of this therapeutic plant as of September 2022.
Through their genomic expertise, the company aims to enable growers, testing labs, and dispensaries to cultivate clean, high-quality cannabis strains more efficiently. Their solutions encompass accurate, automated pathogen and sex testing, as well as advanced genomic tools for optimizing cannabis genetics and identifying beneficial compounds. Medicinal Genomics' proprietary bioinformatics system, ZiPhyr, plays a crucial role in analyzing sequencing data to elucidate the genetic drivers behind cannabis biochemistry.
In June 2022, Medicinal Genomics had compiled a comprehensive compendium of microbial testing regulations for cannabis in legal states, highlighting the need for consistent standards to benefit consumers, growers, and regulators. By leveraging their genomic insights, the company aims to foster the development of therapeutic cannabis products while mitigating psychoactive effects through targeted breeding strategies.

Cresco Labs is a vertically integrated multistate cannabis operator with a focus on delivering consistent quality products across its portfolio of branded offerings. The company cultivates, processes, and distributes a diverse range of cannabis products, including flower, vapes, concentrates, edibles, and pre-rolls. Cresco Labs operates under multiple brands, such as Cresco, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's Edibles, and Remedi, catering to various consumer preferences and occasions.
Cresco's cultivation practices involve rigorous phenotype hunting and small-batch cultivation to ensure premium quality. Their products are meticulously hand-trimmed and expertly cared for throughout the process. The company's brand portfolio aims to provide consistent, reliable, and enjoyable cannabis experiences for consumers, whether they are familiar with the plant or new to it.
As of December 2023, Cresco Labs operated in numerous states across the US, with 21 production facilities and 49 dispensaries under the Sunnyside retail banner. The company has implemented operational changes to improve its environmental impact and formed partnerships, such as with Temple University, to explore the potential healing properties of cannabis.
In February 2023, Cresco Labs expanded its retail presence by opening a new Sunnyside dispensary in Daytona Beach, Florida, marking its 23rd location in the state and 58th nationwide. The company reported generating revenue of approximately USD 822 million for the full year 2021.

Cresco Labs

<div>
 
 BZAM Ltd is a multi-licensed Canadian cannabis producer focused on branded consumer goods, innovation, quality, consistency, integrity, and transparency. The company cultivates and produces premium, organically grown cannabis products across its facilities in British Columbia, Alberta, Ontario, and Quebec. BZAM serves the recreational market with a diverse brand portfolio, including The Green Organic Dutchman, -ness, Highly Dutch Organics, TABLE TOP, Cruuzy, and partner brands like Dunn Cannabis, FRESH, Superflower, and Snackbar.
 
</div>

BZAM Ltd

<div>
 
 TerrAscend is a leading North American cannabis operator with vertically integrated operations in California, Maryland, Michigan, New Jersey, and Pennsylvania, as well as retail operations in Canada. The company focuses on growing high-quality cannabis, promoting its health benefits, and offering a diverse range of products tailored to the needs of medical patients and adult-use consumers. TerrAscend utilizes advanced cultivation techniques, innovative cannabis cultivars, and strategic technology investments to produce premium cannabis products.
 
 
 
 
 In March 2022, TerrAscend completed the acquisition of Gage Growth Corp., a prominent cannabis brand and operator, in a deal valued at over USD 545 million. This strategic acquisition aimed to create a differentiated and compelling player in the North American cannabis market, combining TerrAscend's proven cultivation and manufacturing expertise with Gage's top-selling brands and exceptional retail experiences.
 
 
 
 
 As of January 2023, TerrAscend operated 32 dispensaries nationwide under its award-winning retail concepts, The Apothecarium and Gage. The company's portfolio includes several synergistic businesses and brands, such as Gage Cannabis, Ilera healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. In May 2023, TerrAscend strengthened its balance sheet by selling a facility in Canada for CADUSD 19.7 million, using the proceeds to pay down existing debt.
 
</div>

TerrAscend

Holistic Industries is a multistate cannabis company that specializes in cultivating, manufacturing, and distributing a diverse range of premium cannabis products. Their portfolio includes Liberty Cannabis flower strains, meticulously grown and sustainably cultivated to offer an exceptional experience across indica, sativa, and hybrid varieties. Holistic Industries also produces Strane vape cartridges, crafted with CO2-extracted cannabis oil and all-natural terpenes for a smooth and flavorful vaping experience. Additionally, they offer Strane concentrates in various forms, such as shatter, wax, and live resin, catering to consumers seeking potency and purity. The company's product line further encompasses Holistic Remedies, a collection of topicals and tinctures, as well as elixirs and edibles, including cannabis-infused sparkling waters and chocolates, providing precise dosing and delicious flavors.
Holistic Industries places a strong emphasis on quality control, subjecting their products to rigorous testing processes to ensure they are free from contaminants, pesticides, and consistently meet high standards. The company collaborates with scientists, medical professionals, and researchers to develop cutting-edge cannabis formulations and products. Furthermore, Holistic Industries prioritizes sustainable practices, demonstrating a commitment to environmental responsibility.
In December 2023, Holistic Industries launched the Garcia Hand Picked cannabis brand, a collaboration with the family of Grateful Dead guitarist Jerry Garcia, after years of sampling countless strains to find one worthy of his name.

Holistic Industries

<div>
 
 Flower One is a Nevada-based cannabis cultivator and producer focused on the state's lucrative cannabis market. The company operates a 455,000 square-foot greenhouse and production facility, the largest in Nevada. As of June 2019, Flower One commenced continuous harvest operations, capable of producing 140,000 lbs (62,500 kg) of dry flower annually from over 100,000 plants across eight flower zones per crop cycle. Additionally, Flower One owns North Las Vegas Organics, a 25,000 square-foot indoor cultivation facility with nine grow rooms that can cultivate 4,500 plants per cycle.
 
 
 
 
 Flower One produces a diverse range of cannabis products, including flower, full-spectrum oils, distillates, pre-rolls, concentrates, edibles, and topicals for various brands. In October 2018, the company acquired NLV Organics, a Las Vegas-based cannabis cultivation business, for USD 27 million, expanding its footprint in Nevada's rapidly growing cannabis industry. As of June 2022, Flower One appointed Tim Shoemake as its new Chief Operating Officer, leveraging his over 25 years of experience in global agriculture and food and beverage manufacturing. Flower One trades on the Canadian Securities Exchange under the ticker symbol &quot;FONE&quot;.
 
 
 
</div>

Flower One

Companies that specialize in growing and refining cannabis.

Companies that distribute and sell cannabis and cannabis-related products.

Companies that extract cannabinoids to create cannabis-related medication or edibles.

Companies that carry out medical consultations to prescribe cannabis.

Companies that either provide consultations, educate, or carry out testing of cannabis products.

Some startups employ sustainable farming practices when cultivating cannabis

Medicinal Genomics

Sources

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless